The Heart Whisperer: How Dr. Fred Apple Transformed Cardiac Diagnostics
ABOUT: This feature profile highlights the career legacy and scientific advancements of cardiovascular medicine researcher, Dr. Fred Apple. This story explores the groundbreaking discoveries and advancements of Dr. Fred Apple and the Cardiac Biomarkers Trial Lab (CBTL) in myocardial infarction (heart attack) diagnostic lab testing and improving patient care.
Role: Interviewer | Writer | Editor | Visual Curator Publisher
Duties: I led this story from start to finish—interviewing the subject, translating scientific and technical information into an easy-to-digest format by crafting the narrative with a human-centered focus. I refined the piece through multiple editing rounds, including scientific peer review for factual accuracy. Finally, I sourced, curated, and captioned all of the visuals (including this slideshow) and published the final story on WordPress.
Published in: HHRI News, 2025
Summary: As Principal Investigator of the Cardiac Biomarkers Trial Lab (CBTL), Dr. Apple has led more than 450 clinical studies and built long-term partnerships to validate new diagnostic tools. In addition to his research, he’s an influential educator and mentor, shaping future leaders in lab medicine. As he inches closer to retirement, he’s ensuring a lasting legacy by establishing a $1 million endowed scholar fund in his parents' name to support emerging experts in laboratory medicine.
This is a short video slideshow of Dr. Fred Apple and his colleagues throughout his decade-spanning career.
“Before working in this field, I, like many others, didn’t fully appreciate the enormous infrastructure behind something as ‘routine’ as a blood test. When people are sick, they go to the doctor, have blood drawn, and receive a diagnosis, often without realizing that it’s the clinical laboratory that generates the data guiding that diagnosis. Dr. Apple has helped me see that our work in the lab isn’t behind the scenes; it’s at the heart of modern medicine."